R76.12
Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis
Clinical Classification Guidelines
Inclusion Terms
- Nonspecific reaction to QuantiFERON-TB test (QFT) without active tuberculosis
Excludes Type 1
- nonspecific reaction to tuberculin skin test without active tuberculosis (R76.11)
- positive tuberculin skin test (R76.11)
Medical Intelligence & Overview
The diagnosis coded as R76.12 describes a nonspecific reaction observed during the measurement of cell-mediated immunity, specifically involving the gamma interferon antigen response. This test, often referred to as the QuantiFERON-TB test or QFT, is used to help determine if someone has been infected with tuberculosis (TB). However, in this case, the test reaction is nonspecific and does not indicate active tuberculosis disease. It's an important distinction that helps healthcare professionals interpret test results accurately to guide further medical decisions.
Causes & Symptoms
Clinical Causes: Prior tuberculosis infection that is inactive Latent tuberculosis infection not currently causing symptoms Other immune responses unrelated to active TB Recent exposure to TB with immune response testing before disease develops Non-specific immune activity or reactions unrelated to TB
Key Symptoms: No noticeable symptoms; often an incidental finding during testing Possible mild immune reactions such as localized swelling or skin reaction at the test site Absence of active tuberculosis symptoms such as cough, fever, weight loss, or night sweats General feelings of fatigue or malaise if related to other immune system factors
Diagnostic & Treatment
Diagnosis Path: The diagnosis of a nonspecific reaction to the cell-mediated immunity measurement involves interpreting the results of the gamma interferon antigen response test. Healthcare providers consider the test's outcome alongside medical history, possible TB exposure, and clinical presentation. Since no active infection or disease symptoms are present, further testing, monitoring, or clinical evaluation may be recommended to rule out latent TB infection or other immune-related issues.
Treatment Protocols: There is no specific treatment for a nonspecific immune reaction itself. Management focuses on thorough assessment to determine if latent TB infection exists or if additional testing is necessary. If latent TB is suspected, preventive therapy might be considered, but this decision rests on comprehensive clinical evaluation. Follow-up may include additional imaging, repeat testing, or immunological assessments depending on individual circumstances.
Clinical Advice & FAQs
Billing Guidance
Is R76.12 a billable ICD-10 code?
Yes, R76.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R76.12?
Clinical documentation must specify the nature of Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference